(Q36484539)

14 August 2017

Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus (English)

1 reference

methicillin-resistant Staphylococcus aureus

14 August 2017

0 references

Staphylococcus aureus

1 reference

10

Victor Nizet

0 references

George Sakoulas

9

object named as

George Sakoulas

1 reference

14 August 2017

8

William Fenical

1 reference

14 August 2017

Nina M Haste

1

1 reference

14 August 2017

Wdee Thienphrapa

2

1 reference

14 August 2017

Dan N Tran

3

1 reference

14 August 2017

Sandra Loesgen

4

1 reference

14 August 2017

Peng Sun

5

1 reference

14 August 2017

Sang-Jip Nam

6

1 reference

14 August 2017

Paul R Jensen

7

1 reference

14 August 2017

Mary E Hensler

11

1 reference

14 August 2017

10 October 2012

1 reference

The Journal of Antibiotics

14 August 2017

1 reference

14 August 2017

65

1 reference

14 August 2017

12

1 reference

14 August 2017

593-598

1 reference

https://scigraph.springernature.com/pub.10.1038/ja.2012.77

14 August 2017

0 references

cites work

Novel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Pharmacological properties of the marine natural product marinopyrrole A against methicillin-resistant Staphylococcus aureus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Recent advances in the chemistry and biology of naturally occurring antibiotics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

30 September 2017

Thiopeptide antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Glycothiohexides, novel antibiotics produced by "Sebekia" sp. LL-14E605. I. Taxonomy, fermentation and biological evaluation.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Effect of nosiheptide as a feed additive in chicks on the quantity, duration, prevalence of excretion, and resistance to antibacterial agents of Salmonella typhimurium; on the proportion of Escherichia coli and other coliforms resistant to antibacte

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

Glycothiohexide alpha, a novel antibiotic produced by "Sebekia" sp., LL-14E605. III. Structural elucidation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

The Mode of Action of Nosiheptide (Multhiomycin) and the Mechanism of Resistance in the Producing Organism

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528839

On the mode of action of multhiomycin. I. Effects of multhiomycin on macromolecular syntheses

21 October 2018

1 reference

12 December 2020

A new antibiotic, multhiomycin

1 reference

12 December 2020

Glycothiohexide alpha, a novel antibiotic produced by "Sebekia" sp., LL-14E605. II. Isolation and physical-chemical characterization

1 reference

12 December 2020

1H and 13C NMR assignments of the thiopeptide antibiotic nosiheptide

1 reference

12 December 2020

Identifiers

DOI

10.1038/JA.2012.77

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23047246

1 reference